Cargando…

Immunomodulatory Effects of Cell Therapy after Myocardial Infarction

Detalles Bibliográficos
Autores principales:	Moore, Joseph B, Wysoczynski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098722/ https://www.ncbi.nlm.nih.gov/pubmed/33959728 http://dx.doi.org/10.33696/immunology.3.082

Ejemplares similares

Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice
por: Kang, Yi, et al.
Publicado: (2020)

Extracellular Matrix Biomaterial Therapy for Myocardial Infarction: New Delivery Route and Immunomodulatory Effects
por: Christman, Karen L.
Publicado: (2023)

Immunomodulatory effects of icariin in a myocardial infarction mouse model
por: Sai, Xiyalatu, et al.
Publicado: (2022)

Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation
por: Nian, Wenjian, et al.
Publicado: (2023)

Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial Infarction
por: Kong, Pengxu, et al.
Publicado: (2023)

Therapy Discontinuation after Myocardial Infarction
por: Pietrzykowski, Łukasz, et al.
Publicado: (2020)

Immunomodulatory Action of Substituted 1,3,4-Thiadiazines on the Course of Myocardial Infarction
por: Sarapultsev, Alexey P., et al.
Publicado: (2018)

Macrophage Long Non-Coding RNAs in Pathogenesis of Cardiovascular Disease
por: Wysoczynski, Marcin, et al.
Publicado: (2020)

Myocardial salvage after myocardial infarction depends on early therapy
Publicado: (2010)

Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction
por: Malliaras, Konstantinos, et al.
Publicado: (2014)

Thrombolytic therapy for myocardial infarction facilitated by mobile coronary care.
por: Wilson, C., et al.
Publicado: (2004)

Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction
por: Monguió-Tortajada, Marta, et al.
Publicado: (2021)

Novel insights into the mechanism of cell-based therapy after chronic myocardial infarction
por: Schuh, Alexander, et al.
Publicado: (2014)

Rigor Me This: What Are the Basic Criteria for a Rigorous, Transparent, and Reproducible Scientific Study?
por: Sansbury, Brian E., et al.
Publicado: (2022)

Elabela gene therapy promotes angiogenesis after myocardial infarction
por: Jin, Liangli, et al.
Publicado: (2021)

Effects of Cell Grafting on Coronary Remodeling After Myocardial Infarction
por: Weyers, Jill J., et al.
Publicado: (2013)

The Role of Disopyramide after Myocardial Infarction
por: Jones, M. B. S.
Publicado: (1976)

Engineering Immunomodulatory Biomaterials for Regenerating the Infarcted Myocardium
por: Bloise, Nora, et al.
Publicado: (2020)

Assessing Myocardial Perfusion after Myocardial Infarction
por: Ashrafian, Houman, et al.
Publicado: (2006)

Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking
por: Adamiak, Mateusz, et al.
Publicado: (2016)

Non-ST-elevation myocardial infarction after a wasp sting
por: Gawlik, Radoslaw, et al.
Publicado: (2014)

Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction
por: Nair, Raunak, et al.
Publicado: (2021)

Cellular Therapy for Repair of Cardiac Damage after Acute Myocardial Infarction
por: Cook, Matthew M., et al.
Publicado: (2009)

Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
por: Haraguchi, Yumiko, et al.
Publicado: (2020)

Fimasartan for Remodeling after Myocardial Infarction
por: Lim, Byung-Kwan, et al.
Publicado: (2019)

Early Ambulation after Myocardial Infarction
por: Evans, D. Wainwright
Publicado: (1983)

Disability in the Elderly after Myocardial Infarction
por: Peach, Hedley, et al.
Publicado: (1979)

Smoking Habits after Myocardial Infarction
por: Lloyd, G. G., et al.
Publicado: (1980)

Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
por: Moggio, Aldo, et al.
Publicado: (2022)

Myocardial infarction after taking zolmitriptan.
por: Pacheco-Coronado, Roberto, et al.
Publicado: (2005)

Lymphangiogenesis in myocardial remodelling after infarction
por: Ishikawa, Y, et al.
Publicado: (2007)

Financial Stress and Outcomes after Acute Myocardial Infarction
por: Shah, Sachin J., et al.
Publicado: (2012)

Infarct Size as Predictor of Systolic Functional Recovery after Myocardial Infarction
por: Minicucci, Marcos F., et al.
Publicado: (2014)

Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
por: Mohmand, Billal, et al.
Publicado: (2021)

Patient Adherence to Therapy After Myocardial Infarction: A Scoping Review
por: Zorina, Olga, et al.
Publicado: (2022)

Pregnancy after myocardial infarction and coronary artery bypass grafting – is it safe?
por: Janion-Sadowska, Agnieszka, et al.
Publicado: (2014)

Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion
por: Moore, Joseph B., et al.
Publicado: (2017)

Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction
por: Wang, Yu, et al.
Publicado: (2022)

Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
por: Minicucci, Marcos F., et al.
Publicado: (2013)

Incidence of Stroke After Myocardial Infarction
por: Tabrizchi, Reza
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_f6qvl8cqglfbqrsr2v70oh8vbb